Portability of a Small-Molecule Binding Site between Disordered Proteins

Biomolecules. 2022 Dec 16;12(12):1887. doi: 10.3390/biom12121887.

Abstract

Intrinsically disordered proteins (IDPs) are important in both normal and disease states. Small molecules can be targeted to disordered regions, but we currently have only a limited understanding of the nature of small-molecule binding sites in IDPs. Here, we show that a minimal small-molecule binding sequence of eight contiguous residues derived from the Myc protein can be ported into a different disordered protein and recapitulate small-molecule binding activity in the new context. We also find that the residue immediately flanking the binding site can have opposing effects on small-molecule binding in the different disordered protein contexts. The results demonstrate that small-molecule binding sites can act modularly and are portable between disordered protein contexts but that residues outside of the minimal binding site can modulate binding affinity.

Keywords: Myc; SLiM; drug targets; intrinsically disordered proteins; protein-protein interaction; small-molecule inhibitors.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Biophysical Phenomena
  • Intrinsically Disordered Proteins* / chemistry
  • Protein Binding

Substances

  • Intrinsically Disordered Proteins